|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2022―Mai―05 |
Exercise oncology during and beyond the COVID-19 pandemic: are virtually supervised exercise interventions a sustainable alternative? |
Paola Gonzalo-Encabo, Rebekah L. Wilson, Dong-Woo Kang, Amber J. Normann, Christina M. Dieli-Conwright |
2 |
[GO] |
2022―Mrz―23 |
Organisation of cancer care in troubling times: a scoping review of expert guidelines and their implementation during the COVID-19 pandemic |
Brenda Bogaert, Victoria Buisson, Zizis Kozlakidis, Pierre Saintigny |
3 |
[GO] |
2021―Nov―17 |
COVID-19 and Immunothrombosis: Pathophysiology and therapeutic implications |
Ming Sheng Lim, Simon Mcrae |
4 |
[GO] |
2021―Okt―08 |
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review |
Orazio Caffo, Marco Messina, Antonello Veccia, Stefania Kinspergher, Francesca Maines, Carlo Messina |
5 |
[GO] |
2021―Jun―30 |
Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines |
Zahra Siavashpour, Neda Goharpey, Mosayyeb Mobasheri |
6 |
[GO] |
2021―Mai―27 |
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis |
Marco Tagliamento, Elisa Agostinetto, Marco Bruzzone, Marcello Ceppi, Kamal S. Saini, Evandro de Azambuja, et al. (+7) Kevin Punie, C. Benedikt Westphalen, Gilberto Morgan, Paolo Pronzato, Lucia Del Mastro, Francesca Poggio, Matteo Lambertini |
7 |
[GO] |
2021―Mrz―18 |
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea |
Marc Boutros, Elissar Moujaess, Hampig Raphael Kourie |
8 |
[GO] |
2021―Feb―26 |
The effect of COVID-19 pandemic on daily oncology clinical practice |
Giovanni Codacci-Pisanelli, Jacopo Giuliani, Andrea Bonetti |
9 |
[GO] |
2021―Feb―26 |
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients |
Fotios Loupakis, Raffaele Giusti, Massimo Di Maio |
10 |
[GO] |
2020―Nov―27 |
Italian Survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: a lesson for the second wave |
Valentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, Erica Palesandro, Annapaola Mariniello, Gianmarco Leone, et al. (+11) Fabrizio Tabbò, Maristella Bungaro, Marco Audisio, Simonetta Rapetti, Rosario Francesco Di Stefano, Simona Carnio, Elisa Artusio, Enrica Capelletto, Paola Sperone, Francesco Passiglia, Silvia Novello |
11 |
[GO] |
2020―Nov―19 |
De-escalating cancer treatments during COVID 19 pandemic: is metronomic chemotherapy a reasonable option? |
Palma Fedele, Valeria Sanna, Alessandro Fancellu, Antonella Marino, Nicola Calvani, Saverio Cinieri |
12 |
[GO] |
2020―Nov―11 |
A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: utopia or reality? |
Davide Dalu, Selene Rota, Maria Silvia Cona, Anna Maria Brambilla, Sabrina Ferrario, Anna Gambaro, et al. (+4) Luca Meroni, Stefania Merli, Gabriella Farina, Nicla La Verde |
13 |
[GO] |
2020―Okt―23 |
Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic |
Paola Montenegro, Luis Pinillos, Frank Young, Alfredo Aguilar, Indira Tirado-Hurtado, Joseph A. Pinto, Carlos Vallejos |
14 |
[GO] |
2020―Okt―10 |
Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective |
Hatoon Bakhribah, Mohammad Zeitouni, Rayyan A. Daghistani, Hatim Q. Almaghraby, Azzam A. Khankan, Khaled M. Alkattan, et al. (+2) Salem M Alshehri, Abdul Rahman Jazieh |
15 |
[GO] |
2020―Jul―09 |
Coronavirus infection and immune system: an insight of COVID-19 in cancer patients |
Alice Indini, Erika Rijavec, Michele Ghidini, Claudia Bareggi, Monica Cattaneo, Barbara Galassi, et al. (+2) Donatella Gambini, Francesco Grossi |
16 |
[GO] |
2020―Jun―20 |
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: The THOCOoP cooperative group |
Oscar Arrieta, Andrés F. Cardona, Luis Lara, David Heredia, Feliciano Barrón, Zyanya Lucia Zatarain-Barrón, et al. (+38) Francisco Lozano, Vladmir Cordeiro de Lima, Federico Maldonado, Francisco Corona-Cruz, Maritza Ramos, Luis Cabrera, Claudio Martin, Luis Corrales, Mauricio Cuello, Marisol Arroyo-Hernández, Enrique Aman, Ludwing Bacon, Renata Baez, Sergio Benitez, Antonio Botero, Mauricio Burotto, Christian Caglevic, Gustavo Ferraris, Helano Freitas, Diego Lucas Kaen, Sebastián Lamot, Gustavo Lyons, Luis Mas, Andrea Mata, Clarissa Mathias, Alvaro Muñoz, Ana Karina Patane, George Oblitas, Luis Pino, Luis E. Raez, Jordi Remon, Leonardo Rojas, Christian Rolfo, Alejandro Ruiz-Patiño, Suraj Samtani, Lucia Viola, Santiago Viteri, Rafael Rosell |
17 |
[GO] |
2020―Mai―12 |
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-Cancer treatments |
Anya Jafari, Sahar Dadkhahfar, Sahra Perseh |
18 |
[GO] |
2020―Apr―22 |
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence |
Elissar Moujaess, Hampig Raphael Kourie, Marwan Ghosn |